Beth Hecht
Officer at Xeris Biopharma Holdings, Inc. (XERS)
Beth Hecht has filed 38 insider reports with the SEC since February 2021, as officer at Xeris Biopharma Holdings, Inc. (XERS), director at Iterum Therapeutics plc (ITRM) and director at Aytu Biopharma, Inc (AYTU) and at 1 more company. In the last 12 months Beth Hecht sold $1.72M of stock on the open market. On November 2, 2026 Beth Hecht filed a Form 144 notice and plans to sell 75,000 XERS shares (~$803K). In the latest filing, on November 4, 2026, Beth Hecht sold 25,000 shares of Xeris Biopharma Holdings, Inc. (XERS) for $256K at an average of $10.23.
Planned sale (Form 144)
- Beth Hecht plans to sell 75,000 XERS shares (~$803K), around Nov 2, 2026. Notice filed Nov 2, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 38
- Companies
- 4
- Bought on market
- None
- Sold on market
- $1.94M
Companies where Beth Hecht is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 1,086,130 | $1.94M | $16.65 | Nov 4, 2026 | |||
| Directorsince March 2012 | 18,839 | Jun 15, 2023 | |||||
| Directorsince March 2021 | 9,052 | $1.79 | Apr 12, 2021 | ||||
| Director | 0 | Mar 19, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 2, 2026-$256KXERSOfficer Hecht Beth sold $255,828 worth of shares (25,000 units at $10.23) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,086,130 unitsForm 4Open-market sale10b5-1 plan
- Nov 2, 2026~$803KXERSBeth Hecht plans to sell 75,000 shares (~$803K)Form 144Planned sale10b5-1 plan
- Oct 1, 2026-$157KXERSOfficer Hecht Beth sold $156,792 worth of shares (16,666 units at $9.41) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,111,130 unitsForm 4Open-market sale10b5-1 plan
- Oct 1, 2026~$159KXERSBeth Hecht plans to sell 16,666 shares (~$159K)Form 144Planned sale10b5-1 plan
- Sep 1, 2026-$141KXERSOfficer Hecht Beth sold $141,434 worth of shares (16,666 units at $8.49) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,127,796 unitsForm 4Open-market sale10b5-1 plan
- Aug 3, 2026-$134KXERSOfficer Hecht Beth sold $133,553 worth of shares (16,666 units at $8.01) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,144,462 unitsForm 4Open-market sale10b5-1 plan
- Jul 1, 2026-$134KXERSOfficer Hecht Beth sold $133,860 worth of shares (16,666 units at $8.03) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,161,128 unitsForm 4Open-market sale10b5-1 plan
- Jul 1, 2026~$396KXERSBeth Hecht plans to sell 49,998 shares (~$396K)Form 144Planned sale10b5-1 plan
- Jun 1, 2026-$101KXERSOfficer Hecht Beth sold $100,982 worth of shares (16,667 units at $6.06) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,176,506 unitsForm 4Open-market sale10b5-1 plan
- May 1, 2026-$104KXERSOfficer Hecht Beth sold $103,805 worth of shares (16,667 units at $6.23) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,193,173 unitsForm 4Open-market sale10b5-1 plan
- Apr 1, 2026-$99.9KXERSSEC Form 4 filed by Hecht BethForm 4Open-market sale10b5-1 plan
- Mar 2, 2026-$104KXERSOfficer Hecht Beth sold $104,086 worth of shares (16,667 units at $6.25), decreasing direct ownership by 1% to 1,226,507 unitsForm 4Open-market sale10b5-1 plan
- Mar 2, 2026~$408KXERSBeth Hecht plans to sell 66,668 shares (~$408K)Form 144Planned sale10b5-1 plan
- Feb 2, 2026-$124KXERSOfficer Hecht Beth was granted 121,293 shares, covered exercise/tax liability with 169,555 shares and sold $124,147 worth of shares (16,667 units at $7.45), decreasing direct ownership by 5% to 1,243,174 unitsForm 4Grant or awardShares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Jan 2, 2026-$124KXERSOfficer Hecht Beth sold $123,776 worth of shares (16,667 units at $7.43), decreasing direct ownership by 1% to 1,308,103 unitsForm 4Open-market sale10b5-1 plan
- Dec 1, 2025-$117KXERSOfficer Hecht Beth sold $116,781 worth of shares (16,667 units at $7.01), decreasing direct ownership by 1% to 1,320,176 unitsForm 4Open-market sale10b5-1 plan
- Nov 11, 2025-$123KXERSOfficer Hecht Beth sold $123,296 worth of shares (16,667 units at $7.40), decreasing direct ownership by 1% to 1,336,843 unitsForm 4Open-market sale10b5-1 plan
- Nov 11, 2025~$515KXERSBeth Hecht plans to sell 66,668 shares (~$515K)Form 144Planned sale10b5-1 plan
- Mar 20, 2025-$217KXERSOfficer Hecht Beth sold $217,244 worth of shares (40,000 units at $5.43), decreasing direct ownership by 3% to 1,353,510 unitsForm 4Open-market sale
- Mar 20, 2025~$206KXERSBeth Hecht plans to sell 40,000 shares (~$206K)Form 144Planned sale
- Jan 31, 2025XERSOfficer Hecht Beth covered exercise/tax liability with 144,284 shares and was granted 185,000 shares, increasing direct ownership by 3% to 1,393,510 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Jan 3, 2025XERSOfficer Hecht Beth covered exercise/tax liability with 32,039 shares, decreasing direct ownership by 2% to 1,352,794 unitsForm 4Shares withheld for taxes or exercise price
- Jan 31, 2024XERSOfficer Hecht Beth covered exercise/tax liability with 178,006 shares, decreasing direct ownership by 11% to 1,380,802 unitsForm 4Shares withheld for taxes or exercise price
- Jan 31, 2024XERSHecht Beth was granted 750,000 shares, increasing direct ownership by 93% to 1,554,968 unitsForm 4Grant or award
- Jun 15, 2023ITRMSEC Form 4 filed by Hecht BethForm 4Exercise or conversion of a derivative
- Jan 31, 2023XERSSEC Form 4: Hecht Beth was granted 350,000 shares, increasing direct ownership by 78% to 797,758 unitsForm 4Grant or award
- Jun 23, 2022ITRMSEC Form 4: Hecht Beth converted options into 36,798 units of Ordinary Shares, increasing direct ownership by 460% to 44,805 unitsForm 4Exercise or conversion of a derivative
- Jun 15, 2022ITRMSEC Form 4 filed by Hecht BethForm 4Grant or award
- Mar 18, 2022ITRMSEC Form 4: Hecht Beth converted options into 7,642 units of Ordinary Shares, increasing direct ownership by 2,094% to 8,007 unitsForm 4Exercise or conversion of a derivative
- Jan 3, 2022XERSSEC Form 4: Hecht Beth was granted 225,000 shares, increasing direct ownership by 106% to 436,821 unitsForm 4Grant or award
- Oct 5, 2021XERSSEC Form 4: Hecht Beth returned 206,366 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Jun 23, 2021ITRMSEC Form 4 filed by Hecht BethForm 4Grant or award
- Mar 12, 2012ITRMSEC Form 3: Hecht Beth claimed ownership of 365 units of Ordinary SharesForm 3New insider
- Apr 8, 2021AYTUSEC Form 4: Beth Hecht was granted 6,500 units of Common Stock, increasing direct ownership by 255% to 9,052 unitsForm 4Grant or award
- Mar 19, 2021AYTUSEC Form 3: Beth Hecht claimed ownership of 2,552 units of Common StockForm 3New insider
- Mar 19, 2021NEOSSEC Form 4: Beth Hecht disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 unitsForm 4Sale back to the company
- Mar 18, 2021ITRMSEC Form 4 filed by Beth HechtForm 4Grant or award
- Jan 29, 2021XERSSEC Form 4: Beth Hecht was granted 150,000 units of Common Stock, increasing ownership by 247% to 210,814 unitsForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Beth Hecht.
- John P. Schmid2 shared: XERS, NEOS
- Gerald W. McLaughlin2 shared: AYTU, NEOS
- Richard I Eisenstadt2 shared: AYTU, NEOS
Compare Beth Hecht with
- Beth Hecht vs John P. Schmid2 shared
- Beth Hecht vs Gerald W. McLaughlin2 shared
- Beth Hecht vs Richard I Eisenstadt2 shared
- Beth Hecht vs Kevin McCulloch1 shared
- Beth Hecht vs Steven Pieper1 shared
- Beth Hecht vs Menassie Taddese1 shared
Other insiders at the same companies
- Kevin McCullochXERS
- Steven PieperXERS
- Menassie TaddeseXERS
- John Patrick Shannon JrXERS
- Joshua R. DisbrowAYTU
- Greg PyszczymukaAYTU
- Jarrett DisbrowAYTU
- Ryan J SelhornAYTU
- Vivian H LiuAYTU
- Carl DockeryAYTU
- Abhinav JainAYTU
- John Donofrio Jr.AYTU
- Nerissa KreherXERS
- Garheng KongXERS
- Marla PerskyXERS
- Barbara-Jean Anne Bormann-KennedyXERS
Questions about Beth Hecht
- What is Beth Hecht's role at Xeris Biopharma Holdings, Inc.?
- Beth Hecht reports to the SEC as officer at Xeris Biopharma Holdings, Inc. (XERS), according to the latest filing on November 4, 2026. Beth Hecht has also filed as director at Iterum Therapeutics plc (ITRM), director at Aytu Biopharma, Inc (AYTU) and director at Neos Therapeutics, Inc. (NEOS).
- How many shares does Beth Hecht own?
- After the latest filing that states it, Beth Hecht directly owned 1,086,130 shares of Xeris Biopharma Holdings, Inc. (XERS), 18,839 shares of Iterum Therapeutics plc (ITRM) and 9,052 shares of Aytu Biopharma, Inc (AYTU). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Beth Hecht bought or sold stock recently?
- The most recent open-market sale was on November 2, 2026: sold 25,000 shares of Xeris Biopharma Holdings, Inc. (XERS) for $256K at an average of $10.23.
- How do I get alerts when Beth Hecht files?
- Follow Beth Hecht on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Beth Hecht filed 5 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Beth Hecht (SEC CIK 0001652410). Totals count each trade once, skipping amendments whose original is on file, from Feb 1, 2021 on. View on SEC EDGAR